WallStreetZenWallStreetZen

NASDAQ: RANI
Rani Therapeutics Holdings Inc Stock Ownership - Who owns Rani Therapeutics Holdings?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Rani Therapeutics Holdings Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kate McKinleyChief Business Officer2024-12-1317,960$1.67
$29.99kBuy
Talat ImranChief Executive Officer2024-12-0910,296$1.94
$19.97kBuy
South Cone Investments Limited Partnership10% Owner2024-10-153,305,622$2.55
$8.44MSell
South Cone Investments Limited Partnership10% Owner2024-10-15523,738$3.26
$1.71MSell

1 of 1

RANI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RANI insiders and whales buy or sell their stock.

RANI Shareholders

What type of owners hold Rani Therapeutics Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
South Cone Investments Limited Partnership25.89%14,898,682$7.64MInsider
Moreno Isidoro Quiroga9.16%5,272,750$2.70MInsider
Vanguard Group Inc1.39%799,679$410.24kInstitution
Talat Imran0.88%507,094$260.14kInsider
Nan Fung Group Holdings Ltd0.86%493,584$253.21kInstitution
Alphabet Inc0.78%448,492$230.08kInstitution
Andrew Farquharson0.71%406,768$208.67kInsider
United Services Automobile Association0.53%302,743$155.31kInstitution
Mir Hashim0.47%273,265$140.18kInsider
Svai S. Sanford0.45%258,597$132.66kInsider

1 of 3

RANI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RANI6.27%38.43%Net Selling
ESLA1.70%82.00%
OKUR32.02%67.98%Net BuyingNet Selling
ANTX39.55%60.45%Net SellingNet Selling
INKT0.26%99.74%Net BuyingNet Buying
View Top Biotech Stocks

Rani Therapeutics Holdings Stock Ownership FAQ

Who owns Rani Therapeutics Holdings?

Rani Therapeutics Holdings (NASDAQ: RANI) is owned by 6.27% institutional shareholders, 38.43% Rani Therapeutics Holdings insiders, and 55.30% retail investors. South Cone Investments Limited Partnership is the largest individual Rani Therapeutics Holdings shareholder, owning 14.90M shares representing 25.89% of the company. South Cone Investments Limited Partnership's Rani Therapeutics Holdings shares are currently valued at $7.93M.

If you're new to stock investing, here's how to buy Rani Therapeutics Holdings stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.